153 related articles for article (PubMed ID: 7133977)
1. [Management of polycythaemia with pipobroman].
Perreau-Boutet MC; Najman A; Stachowiak J; Parlier Y; Gorin NC; Duhamel G
Nouv Presse Med; 1982 Sep; 11(34):2549-53. PubMed ID: 7133977
[TBL] [Abstract][Full Text] [Related]
2. Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
Boivin P
Nouv Rev Fr Hematol (1978); 1993; 35(5):491-8. PubMed ID: 8295823
[TBL] [Abstract][Full Text] [Related]
3. Pipobroman therapy of polycythemia vera.
Najman A; Stachowiak J; Parlier Y; Gorin NC; Duhamel G
Blood; 1982 May; 59(5):890-4. PubMed ID: 7074217
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trial of pipobroman (N,N'-bis-(3-bromopropionyl) piperazine) in eight patients with polycythemia vera].
Miyazaki T; Ishizaki T; Maekawa I; Sano H; Idaka K
Rinsho Ketsueki; 1972 Oct; 13(5):777-86. PubMed ID: 4674853
[No Abstract] [Full Text] [Related]
5. Efficacy of pipobroman in the treatment of polycythemia vera: long-term results in 163 patients.
Passamonti F; Brusamolino E; Lazzarino M; Baraté C; Klersy C; Orlandi E; Canevari A; Castelli G; Merante S; Bernasconi C
Haematologica; 2000 Oct; 85(10):1011-8. PubMed ID: 11025590
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of polycythemia. II.--Comparison of hydroxyurea with pipobroman in 294 patients less than 65 years of age].
Najean Y; Rain JD; Lejeune F; Echard M; Fermand JP; Gruyer P; Brahimi S
Ann Med Interne (Paris); 1998 Mar; 149(2):94-100. PubMed ID: 11490531
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Vaquez's polycythemia with 1-4, bis-3-bromopropionyl-piperazine. Study of 36 cases].
Bilski-Pasquier G; Blanc CM; Bousser J
Presse Med (1893); 1968 Oct; 76(41):1953-6. PubMed ID: 5248051
[No Abstract] [Full Text] [Related]
8. Efficacy trial of pipobroman in essential thrombocythemia: a study of 24 patients.
Brusamolino E; Canevari A; Salvaneschi L; Merante S; Bernasconi C
Cancer Treat Rep; 1984 Nov; 68(11):1339-42. PubMed ID: 6541969
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies].
Najean Y
Presse Med; 1992 Nov; 21(37):1753-7. PubMed ID: 1488420
[TBL] [Abstract][Full Text] [Related]
10. Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.
Kiladjian JJ; Chevret S; Dosquet C; Chomienne C; Rain JD
J Clin Oncol; 2011 Oct; 29(29):3907-13. PubMed ID: 21911721
[TBL] [Abstract][Full Text] [Related]
11. [Little known treatment of primary polycythemia: pipobroman (apropos of 19 cases)].
Bauters F; Jouet JP; Goudemand M
Lille Med; 1976 Mar; 21(3):202-8. PubMed ID: 950881
[No Abstract] [Full Text] [Related]
12. Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy.
Kiladjian JJ; Gardin C; Renoux M; Bruno F; Bernard JF
Hematol J; 2003; 4(3):198-207. PubMed ID: 12764352
[TBL] [Abstract][Full Text] [Related]
13. A review of the therapeutic agents used in the management of polycythaemia vera.
McMullin MF
Hematol Oncol; 2007 Jun; 25(2):58-65. PubMed ID: 17352450
[TBL] [Abstract][Full Text] [Related]
14. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
Rain JD
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
[TBL] [Abstract][Full Text] [Related]
16. Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia.
Brusamolino E; Salvaneschi L; Canevari A; Bernasconi C
J Clin Oncol; 1984 Jun; 2(6):558-61. PubMed ID: 6374054
[TBL] [Abstract][Full Text] [Related]
17. [Pipobroman in the treatment of some cases of polycythemia vera].
Bignotti G; Visca U; Confalonieri C
Haematologica; 1971; 56(3):157-62. PubMed ID: 5003588
[No Abstract] [Full Text] [Related]
18. Polycythemia vera treated with pipobroman as single agent: low incidence of secondary leukemia in a cohort of patients observed during 20 years (1971-1991).
Petti MC; Spadea A; Avvisati G; Spadea T; Latagliata R; Montefusco E; Cosenza M; Malagnino F
Leukemia; 1998 Jun; 12(6):869-74. PubMed ID: 9639413
[TBL] [Abstract][Full Text] [Related]
19. Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman.
Passamonti F; Lazzarino M
Leuk Lymphoma; 2003 Sep; 44(9):1483-8. PubMed ID: 14565648
[TBL] [Abstract][Full Text] [Related]
20. [Efficacious treatment of a fatal blood disease: polycythemia vera].
Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
